Zobrazeno 1 - 10
of 1 066
pro vyhledávání: '"DNA/RNA heteroduplex"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Masahiro Ohara, Tetsuya Nagata, Rintaro Iwata Hara, Kie Yoshida-Tanaka, Nozomi Toide, Kazunori Takagi, Kazuki Sato, Tomoya Takenaka, Masanori Nakakariya, Kenichi Miyata, Yusuke Maeda, Kazuko Toh, Takeshi Wada, Takanori Yokota
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 35, Iss 3, Pp 102289- (2024)
Antisense oligonucleotides (ASOs) are a therapeutic modality for incurable diseases. However, systemic injection of gapmer-type ASOs causes class-related toxicities, including prolongation of activated partial thromboplastin time (aPTT) and thrombocy
Externí odkaz:
https://doaj.org/article/5176d0a643e54340ac19b6a63de2cbd4
Autor:
Chu, Zhenzhen, Zhang, Baohuan, Zhou, Xuxuan, Yuan, Hui, Gao, Chongqing, Liu, Lihao, Xiao, Yang, Zhang, Jichun, Hong, Jian, Liang, Junjie, Chen, Dong, Yao, Nan
Publikováno v:
In Molecular Therapy - Nucleic Acids 12 December 2023 34
Autor:
Li, Fuying, Ichinose, Keiko, Ishibashi, Satoru, Yamamoto, Syunsuke, Iwasawa, Eri, Suzuki, Motohiro, Yoshida-Tanaka, Kie, Yoshioka, Kotaro, Nagata, Tetsuya, Hirabayashi, Hideki, Mogushi, Kaoru, Yokota, Takanori
Publikováno v:
In Molecular Therapy 5 April 2023 31(4):1106-1122
Autor:
Hidetoshi Kaburagi, Tetsuya Nagata, Mitsuhiro Enomoto, Takashi Hirai, Masaki Ohyagi, Kensuke Ihara, Kie Yoshida-Tanaka, Satoe Ebihara, Ken Asada, Hiroyuki Yokoyama, Atsushi Okawa, Takanori Yokota
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 28, Iss , Pp 910-919 (2022)
Neuropathic pain, a heterogeneous condition, affects 7%–10% of the general population. To date, efficacious and safe therapeutic approaches remain limited. Antisense oligonucleotide (ASO) therapy has opened the door to treat spinal muscular atrophy
Externí odkaz:
https://doaj.org/article/22296da924d746c2af59bc6a87710a40
Autor:
Kaburagi, Hidetoshi, Nagata, Tetsuya, Enomoto, Mitsuhiro, Hirai, Takashi, Ohyagi, Masaki, Ihara, Kensuke, Yoshida-Tanaka, Kie, Ebihara, Satoe, Asada, Ken, Yokoyama, Hiroyuki, Okawa, Atsushi, Yokota, Takanori
Publikováno v:
In Molecular Therapy - Nucleic Acids 14 June 2022 28:910-919
Publikováno v:
In Molecular Therapy 1 June 2022 30(6):2210-2223
Autor:
Zhenzhen Chu, Baohuan Zhang, Xuxuan Zhou, Hui Yuan, Chongqing Gao, Lihao Liu, Yang Xiao, Jichun Zhang, Jian Hong, Junjie Liang, Dong Chen, Nan Yao
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 34, Iss , Pp 102047- (2023)
Pemigatinib, a pan-FGFR inhibitor, is approved to treat intrahepatic cholangiocarcinoma (ICC) harboring FGFR2 fusion mutations. Improving its targeting of FGFR2 fusions remains an unmet clinical need due to its pan selectivity and resistance. Here, w
Externí odkaz:
https://doaj.org/article/7507306281de4ec691ec8fdaab5a1821
Autor:
Ono, Daisuke, Asada, Ken, Yui, Daishi, Sakaue, Fumika, Yoshioka, Kotaro, Nagata, Tetsuya, Yokota, Takanori
Publikováno v:
In Molecular Therapy - Nucleic Acids 5 March 2021 23:1360-1370